Does 5-Amino-1MQ Really Raise My NAD+? Here's What I Tell Patients.

If you've come across 5-Amino-1MQ in our peptide offerings and started digging, you may have noticed something confusing: it isn't technically a peptide. It's a small molecule, not a chain of amino acids, which puts it in a different chemical class than something like BPC-157 or CJC-1295. It sits in that category with us because of what it's used for, not what it is.

What it actually does

5-Amino-1MQ works by inhibiting an enzyme called NNMT, which normally diverts nicotinamide, the raw material your cells use to build NAD+, into a disposal pathway instead, using up your body's main methyl-donor molecule, SAM, in the process. Block NNMT, and there's less competition for that pool, so more nicotinamide is left to become NAD+.

Where the evidence actually stands

Every published result on this compound comes from mouse studies and cell culture work. As of today, there are no completed or registered human trials of 5-Amino-1MQ on ClinicalTrials.gov, under any name I've checked it by. That's not a knock on the biology, which is legitimate and published in serious journals. It just means that anything you hear about how well it works in people, at what dose, or for how long, isn't coming from a clinical trial. I obtain it through a compounding pharmacy rather than as an FDA-approved medication, the same regulatory category most peptide therapies fall into.

Who tends to respond best

Based on the mouse data, 5-Amino-1MQ's effects show up most clearly in the context of obesity and insulin resistance, since that's the metabolic environment where NNMT tends to be overactive in the first place. If your NAD+ concerns are tied more to inflammation or hormone decline than to a metabolic/insulin-resistant picture, I'd point you toward addressing those drivers first rather than starting here. "Works best in insulin-resistant patients" is a clinical impression built on a plausible mechanism, not a claim backed by a human trial.

Is it better than an NAD+ IV or IM injection?

They're not really doing the same job, so "better" isn't quite the right question. An NAD+ IV or injection is direct repletion, putting the finished molecule into your bloodstream. 5-Amino-1MQ doesn't add any NAD+ at all; it's trying to make your own cells build more of it by removing something that's degrading the raw material. The intact NAD+ molecule also has to be broken down outside the cell before your cells can rebuild it internally, true regardless of delivery route, so a high blood level right after an infusion doesn't necessarily mean your cells picked up that much. So the honest comparison is: 5-Amino-1MQ is an unproven-in-humans strategy for boosting your own production, while direct NAD+ infusion is a repletion strategy with its own bioavailability limitations at the cellular level (more on that on our NAD+ guide). Formal outcome trials for either approach are limited, but I do see consistent patient reports of improved energy, mental clarity, and faster recovery with both, real and worth taking seriously, just patient-reported rather than trial data.

Why we don't just test your NAD+ level to see if you need this

You can technically get an NAD+ blood level checked, but there's no established, validated range connecting a specific NAD+ blood level to who will respond to treatment or how much they need, unlike a thyroid panel or testosterone level. A result gives us a data point to track in you over time, but on its own it can't currently tell us whether you "need" NAD+ support the way a low TSH tells us something concrete about your thyroid.

If you're dealing with low energy, slower recovery, or brain fog and you're wondering whether 5-Amino-1MQ belongs in your plan, the more useful starting point is usually a broader look at your metabolic and hormone picture first. If insulin resistance turns out to be part of what's going on, this is exactly the situation where I'd consider adding it.

— Dr. Wilcox

This article is for educational purposes only and does not constitute medical advice. It is not a substitute for an individualized evaluation, diagnosis, or treatment plan from a licensed physician. 5-Amino-1MQ is not FDA-approved and is obtained through a compounding pharmacy; it is not indicated to diagnose, treat, cure, or prevent any disease. No human clinical trial data currently exists for this compound. Always consult your physician before starting any new therapy, particularly if you have a personal or family history of cancer or another serious medical condition.